Atıf Formatları
Cardiovascular drugs and analysis of potential risk factors associated with mortality in severe coronavirus disease 2019 patients
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

R. D. Atabey Et Al. , "Cardiovascular drugs and analysis of potential risk factors associated with mortality in severe coronavirus disease 2019 patients," REVISTA DA ASSOCIACAO MEDICA BRASILEIRA , vol.68, no.2, pp.176-182, 2022

Atabey, R. D. Et Al. 2022. Cardiovascular drugs and analysis of potential risk factors associated with mortality in severe coronavirus disease 2019 patients. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA , vol.68, no.2 , 176-182.

Atabey, R. D., Aladağ, N., Sipal, A., Akbulut, T., Dogan, Z., & Ozdemir, M., (2022). Cardiovascular drugs and analysis of potential risk factors associated with mortality in severe coronavirus disease 2019 patients. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA , vol.68, no.2, 176-182.

Atabey, Rukiye Et Al. "Cardiovascular drugs and analysis of potential risk factors associated with mortality in severe coronavirus disease 2019 patients," REVISTA DA ASSOCIACAO MEDICA BRASILEIRA , vol.68, no.2, 176-182, 2022

Atabey, Rukiye D. Et Al. "Cardiovascular drugs and analysis of potential risk factors associated with mortality in severe coronavirus disease 2019 patients." REVISTA DA ASSOCIACAO MEDICA BRASILEIRA , vol.68, no.2, pp.176-182, 2022

Atabey, R. D. Et Al. (2022) . "Cardiovascular drugs and analysis of potential risk factors associated with mortality in severe coronavirus disease 2019 patients." REVISTA DA ASSOCIACAO MEDICA BRASILEIRA , vol.68, no.2, pp.176-182.

@article{article, author={Rukiye Derin Atabey Et Al. }, title={Cardiovascular drugs and analysis of potential risk factors associated with mortality in severe coronavirus disease 2019 patients}, journal={REVISTA DA ASSOCIACAO MEDICA BRASILEIRA}, year=2022, pages={176-182} }